Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study
Authors:
- Virendra SinghVSVirendra Singh
- Sahdeb P. DhunganaSDSahdeb P. Dhungana
- Baljinder SinghBSBaljinder Singh
- Rajesh VijayverghiaRVRajesh Vijayverghia
- Chander K. NainCNChander K. Nain
- Navneet SharmaNSNavneet Sharma
- Ashish BhallaABAshish Bhalla
- Pramod K. GuptaPGPramod K. Gupta
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 56 (2) , 348-354
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The effect of 1 month of therapy with midodrine, octreotide‐LAR and albumin in refractory ascites: a pilot studyLiver International, 2009
- Prevention of paracentesis‐induced circulatory dysfunction: midodrine vs albumin. A randomized pilot studyLiver International, 2008
- Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascitesJournal of Hepatology, 2007
- Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized studyHepatology, 2002
- A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with AscitesNew England Journal of Medicine, 2000
- Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascitesHepatology, 1998
- Systolic flow velocity profile in the left ventricular outflow tract in persons free of heart diseaseThe American Journal of Cardiology, 1993
- Peritoneovenous Shunting as Compared with Medical Treatment in Patients with Alcoholic Cirrhosis and Massive AscitesNew England Journal of Medicine, 1989
- The treatment of refractory ascites by the LeVeen shuntJournal of Hepatology, 1986
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976